‫تطبيق سهم يوفر الآن للمستثمرين الأفراد فرصة الاكتتاب في الطرح الأولي لشركة شلفا لإدارة المرافق

الرياض، المملكة العربية السعودية – 21 أكتوبر 2024 – Media OutReach Newswire – تعلن شركة سهم كابيتال أن المستثمرين الأفراد المؤهلين يمكنهم الآن الاشتراك في الطرح العام الأولي (IPO) لشركة شلفا لإدارة المرافق عبر تطبيق سهم. ستستمر فترة الاكتتاب من 20 أكتوبر إلى 28 أكتوبر 2024.  تفاصيل الطرح العام الأولي (IPO): سعر السهم: 61 ريال سعودي […]

‫تطبيق سهم يوفر الآن للمستثمرين الأفراد فرصة الاكتتاب في الطرح الأولي لشركة شلفا لإدارة المرافق Read More

Sahm App Now Open for Retail Subscription to Shalfa Facilities Management IPO

RIYADH, SAUDI ARABIA – Media OutReach Newswire – 21 October 2024 – Sahm Capital announces that qualified retail investors can now subscribe to the Initial Public Offering (IPO) of Shalfa Facilities Management Company through the Sahm App. The subscription period will run from October 20 to October 28, 2024. IPO Details: Share Price: SAR 61 Minimum Subscription: 10 shares Maximum Subscription: 209,990 shares Instructions […]

Sahm App Now Open for Retail Subscription to Shalfa Facilities Management IPO Read More

Leil Storage: Green File Storage for Africa

Leil Storage for Africa TALLINN, Estonia, Oct. 21, 2024 (GLOBE NEWSWIRE) — In alignment with Africa Human Rights Day, Leil Storage announces the expansion of its Green Storage Initiative, an endeavor set to revolutionize file storage across Africa. This initiative underscores commitment to sustainability and affordability, promising a profound impact on the continent’s digital infrastructure. […]

Leil Storage: Green File Storage for Africa Read More

Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset

The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel compound with broad potential to treat brain health diseases Cureverse receives undisclosed upfront payments and is eligible for future milestone-dependent payments and royalties, while retaining rights to commercialize CV-01 in the Republic of […]

Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset Read More

KnowBe4 Sheds Light on the Alarming Trends of Human Trafficking Through Social Engineering in the UAE

DUBAI, UAE, Oct. 21, 2024 (GLOBE NEWSWIRE) — Human trafficking continues to be an issue in the UAE, particularly affecting foreign workers from Africa and South and Southeast Asia. Lured with false promises of high-paying jobs, victims arrive in the UAE only to have their passports confiscated and find themselves in forced labor or even […]

KnowBe4 Sheds Light on the Alarming Trends of Human Trafficking Through Social Engineering in the UAE Read More

DXCM DEADLINE: RLF, A LEADING LAW FIRM, Encourages DexCom, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important October 21 Deadline in Securities Class Action – DXCM

NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, 2024 and July 25, 2024, both dates inclusive (the “Class Period”), of the important October 21, 2024 lead plaintiff deadline. SO WHAT: If you purchased DexCom securities during […]

DXCM DEADLINE: RLF, A LEADING LAW FIRM, Encourages DexCom, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important October 21 Deadline in Securities Class Action – DXCM Read More